Evidence check: VDR in the context of allergy

The question about VDR (Vitamin D receptor) in the context of allergy is scientifically relevant, but the evidence is mixed. VDR is activated by vitamin D and modulates the immune system – influencing T‑cell function and cytokine production involved in allergic responses. Numerous association studies (e.g., on SNPs FokI, BsmI, TaqI, ApaI) have found weak to moderate links with asthma, atopic dermatitis, or allergic rhinitis. However, meta‑analyses often show inconsistent results depending on population, environmental factors, and vitamin D status. Importantly, VDR polymorphisms alone have no diagnostic or predictive value for allergy. They are just one small piece in a complex network of genetics, epigenetics, microbiome, and environment. Consumer DNA tests that list VDR variants frequently overstate their clinical significance. Evidence‑based allergy workup requires history, specific IgE tests, and possibly provocation tests – not gene panels. Based on the provided context, MyBody‑X tests do not include a specific VDR analysis for allergies. Therefore, their utility for allergy assessment is not supported. In summary: VDR is an interesting research target, but currently insufficiently validated for individual allergy prediction or management.